Zhao, X., Zhou, J., Dong, L., Zhang, H., & Ye, Y. (2019). Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation. Chin Med J (Engl).
Chicago Style citaatZhao, Xue-Song, Jing Zhou, Lei Dong, Hui Zhang, en Ying-Jiang Ye. "Durable Response to Olaparib in Pancreatic Duct Adenocarcinoma With Deleterious ARID1A Mutation." Chin Med J (Engl) 2019.
MLA citatieZhao, Xue-Song, et al. "Durable Response to Olaparib in Pancreatic Duct Adenocarcinoma With Deleterious ARID1A Mutation." Chin Med J (Engl) 2019.
Let op: Deze citaties zijn niet altijd 100% accuraat.